GI
CDNA icon

GAMMA Investing’s CareDx CDNA Stock Holding History

GAMMA Investing’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$173K Buy
2,660
+259
+11% +$11.7K 0.01% 1449
2026
Q2 		$68.4K Sell
2,401
-75
-3% -$1.63K ﹤0.01% 2095
2026
Q1 		$43K Sell
2,476
-38
-2% -$719 ﹤0.01% 2278
2025
Q4 		$47.4K Buy
2,514
+181
+8% +$3.03K ﹤0.01% 2109
2025
Q3 		$33.9K Buy
2,333
+47
+2% +$670 ﹤0.01% 2233
2025
Q2 		$44.7K Sell
2,286
-311
-12% -$5.53K ﹤0.01% 2004
2025
Q1 		$46.1K Buy
2,597
+194
+8% +$4.18K ﹤0.01% 1847
2024
Q4 		$51.4K Buy
2,403
+24
+1% +$584 ﹤0.01% 1633
2024
Q3 		$74.3K Buy
2,379
+169
+8% +$4.21K 0.01% 1208
2024
Q2 		$34.3K Buy
2,210
+2,013
+1,022% +$24.3K ﹤0.01% 1469
2024
Q1 		$2.09K Buy
197
+43
+28% +$430 ﹤0.01% 2733
2023
Q4 		$1.32K Buy
+154
New +$1.26K ﹤0.01% 2712

Other funds holding CDNA

HHAA
Henry H. Armstrong Associates Pittsburgh, Pennsylvania $1.12B AUM 9.9% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

GAMMA Investing's CDNA Position: Q3 2026 in Review

GAMMA Investing increased its CareDx (CDNA) stake by 11% in Q3 2026, buying an estimated $11.7K and bringing the position to 2,660 shares worth $173K. The position accounts for 0.01% of the portfolio, ranked #1449.

GAMMA Investing first reported a position in CDNA in Q4 2023 and has held it in 12 quarters since. 4 funds tracked by Wall St. Rank hold CDNA as of Q3 2026.

  • GAMMA Investing held 2,660 shares of CareDx worth $173K as of Q3 2026.
  • GAMMA Investing bought 259 CareDx shares in Q3 2026, an estimated $11.7K.
  • CareDx made up 0.01% of GAMMA Investing's portfolio in Q3 2026, its #1449 holding.
  • GAMMA Investing first reported a position in CareDx in Q4 2023 and has held it in 12 quarters since.
  • 4 funds tracked by Wall St. Rank held CareDx as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.